Literature DB >> 6245823

Ph1-positive leukaemia, including chronic myelogenous leukaemia.

J D Rowley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245823

Source DB:  PubMed          Journal:  Clin Haematol        ISSN: 0308-2261


× No keyword cloud information.
  24 in total

1.  Rapamycin combined with celecoxib enhanced antitumor effects of mono treatment on chronic myelogenous leukemia cells through downregulating mTOR pathway.

Authors:  Jie Li; Liying Xue; Hongling Hao; Ruoyu Li; Jianmin Luo
Journal:  Tumour Biol       Date:  2014-03-30

Review 2.  Discovery of the Philadelphia chromosome: a personal perspective.

Authors:  Peter C Nowell
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  Rapid detection of chimeric bcr/abl mRNAs in acute lymphoblastic and chronic myeloid leukemia by the polymerase chain reaction.

Authors:  J Maurer; E Thiel
Journal:  Blut       Date:  1990-12

Review 4.  Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.

Authors:  Bin E Li; Patricia Ernst
Journal:  Exp Hematol       Date:  2014-09-28       Impact factor: 3.084

5.  Chronic myelogenous leukemia--recent advances in treatment and pathogenesis.

Authors:  A B Deisseroth; S Purohit; A R Lopez
Journal:  West J Med       Date:  1986-03

6.  Assignment of the gene for methylthioadenosine phosphorylase to human chromosome 9 by mouse-human somatic cell hybridization.

Authors:  C J Carrera; R L Eddy; T B Shows; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

7.  Giemsa-11 technique. Applications in the chromosomal characterization of hematologic specimens.

Authors:  H G Morse; T Hays; D Patterson; A Robinson
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

8.  The human myoglobin gene: a third dispersed globin locus in the human genome.

Authors:  A J Jeffreys; V Wilson; A Blanchetot; P Weller; A Geurts van Kessel; N Spurr; E Solomon; P Goodfellow
Journal:  Nucleic Acids Res       Date:  1984-04-11       Impact factor: 16.971

9.  Apparent decrease and elimination of BCR/ABL mRNA-expressing residual cells in patients with chronic myelogenous leukemia after allogeneic bone marrow transplantation.

Authors:  W Lange; R Herkert; J Finke; U Ragoczy; W Siegert; R Mertelsmann; G Dölken
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

10.  Progression in a chemically induced transplantable human pancreas carcinoma.

Authors:  C Madahar; I Parsa
Journal:  Int J Pancreatol       Date:  1987-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.